Nordson Corporation
313.94USD
-2.8600 (-0.90%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $3.43▲ | $3.24 | 6 | 0 |
| Next quarter | $2.61▲ | $2.52 | 2 | 0 |
| Current year | $11.91▲ | $11.53 | 7 | 0 |
| Next year | $12.94▲ | $12.48 | 7 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $3.09 | $3.25 | +0.16 (+5.0%) |
| 2026-04-30 | $2.82 | $2.86 | +0.04 (+1.5%) |
| 2026-01-31 | $2.37 | $2.37 | -0.00 (-0.1%) |
| 2025-10-31 | $2.93 | $3.03 | +0.10 (+3.4%) |
108 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| DA Davidson | Maintained | Buy | $345 $375 | Aug 24, 2026 |
| Oppenheimer | Maintained | Outperform | $335 $370 | Aug 21, 2026 |
| Baird | Maintained | Neutral | $328 $351 | Aug 21, 2026 |
| DA Davidson | Maintained | Buy | $345 | Aug 20, 2026 |
| Keybanc | Maintained | Overweight | $335 $360 | Aug 20, 2026 |
| Oppenheimer | Maintained | Outperform | $325 $335 | May 29, 2026 |
| DA Davidson | Maintained | Buy | $335 $345 | May 27, 2026 |
| BNP Paribas | Maintained | Neutral | $285 $290 | May 22, 2026 |
| DA Davidson | Maintained | Buy | $335 | May 21, 2026 |
| Oppenheimer | Maintained | Outperform | $285 $325 | Feb 24, 2026 |
| DA Davidson | Maintained | Buy | $290 $335 | Feb 23, 2026 |
| Baird | Maintained | Neutral | $278 $314 | Feb 20, 2026 |
| DA Davidson | Maintained | Buy | $290 | Feb 19, 2026 |
| Keybanc | Maintained | Overweight | $295 $335 | Feb 19, 2026 |
| DA Davidson | Maintained | Buy | $285 $290 | Dec 12, 2025 |
| Baird | Maintained | Neutral | $252 $275 | Dec 12, 2025 |
| DA Davidson | Maintained | Buy | $285 | Dec 11, 2025 |
| Keybanc | Maintained | Overweight | $250 $295 | Dec 11, 2025 |
| Oppenheimer | Maintained | Outperform | $260 $275 | Aug 25, 2025 |
| Baird | Maintained | Neutral | $245 $252 | Aug 22, 2025 |
| Keybanc | Maintained | Overweight | $230 $250 | Jul 15, 2025 |
| Oppenheimer | Upgraded from Perform | Outperform | $260 | May 30, 2025 |
| Baird | Maintained | Neutral | $241 $245 | May 30, 2025 |
| Keybanc | Maintained | Overweight | $260 $230 | Apr 8, 2025 |
| Keybanc | Upgraded from Sector Weight | Overweight | $260 | Mar 4, 2025 |
91 filings from 22 insiders · 8 buy / 6 sell over 6m
Officers and directors of NDSN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Morris Milton MayoDirector | Sell | 156 | $316.63 | $49k | Sep 2, 2026 |
| Hall Justin EOfficer, EVP | Tax | 118 | $314.40 | $37k | Sep 1, 2026 |
| MCDONOUGH JENNIFER LGeneral Counsel | Sell | 260 | $336.00 | $87k | Aug 27, 2026 |
| HOPGOOD DANIEL ROYChief Financial Officer | Exercise | 1.3k | $209.73 | $279k | Aug 26, 2026 |
| HOPGOOD DANIEL ROYChief Financial Officer | Sell | 1.3k | $334.29 | $444k | Aug 26, 2026 |
| DEFORD JOHN ADirector | Grant | 84 | $297.78 | $25k | Jul 31, 2026 |
| MAPES CHRISTOPHER LDirector | Grant | 42 | $297.78 | $13k | Jul 31, 2026 |
| CLAYTON ANNETTE KDirector | Grant | 270 | $283.20 | $76k | May 1, 2026 |
| DEFORD JOHN ADirector | Grant | 87 | $288.45 | $25k | Apr 30, 2026 |
| MAPES CHRISTOPHER LDirector | Grant | 43 | $288.45 | $12k | Apr 30, 2026 |
| SUBRAMANIAN SRINIVASOfficer | Sell | 3.1k | $280.00 | $868k | Apr 17, 2026 |
| SUBRAMANIAN SRINIVASOfficer | Exercise | 1.9k | $107.65 | $205k | Apr 17, 2026 |
| MORRIS MILTON MAYODirector | Sell | 245 | $273.87 | $67k | Apr 15, 2026 |
| HALL JUSTIN EOfficer | Sell | 716 | $275.82 | $197k | Apr 8, 2026 |
| NAGARAJAN SUNDARAMChief Executive Officer | Sell | 41.8k | $293.26 | $12.26M | Feb 24, 2026 |
| KELLEY JOSEPH POfficer | Sell | 8.7k | $291.49 | $2.56M | Feb 24, 2026 |
| NAGARAJAN SUNDARAMChief Executive Officer | Exercise | 41.8k | $165.21 | $6.91M | Feb 24, 2026 |
| KELLEY JOSEPH POfficer | Exercise | 8.4k | $189.72 | $1.63M | Feb 24, 2026 |
| KELLEY JOSEPH POfficer | Sell | 23.1k | $289.00 | $6.67M | Feb 23, 2026 |
| KELLEY JOSEPH POfficer | Exercise | 21.0k | $189.72 | $4.06M | Feb 23, 2026 |
No analyst notes on NDSN yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 4 | 3 | 0 | 1 | Hold2.75 |
| 1 mo ago | 0 | 4 | 3 | 0 | 1 | Hold2.75 |
| 2 mo ago | 0 | 5 | 3 | 0 | 1 | Hold2.67 |